Company / Capital Expenditures
cbdMD, Inc. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$190.0K
FY2025
5-year range
$190.0K / $1.3M
FY2021-FY2025
Trend
-36.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $7,967 in FY2018 to $1M in FY2021.
Based on SEC 10-K filings.
$190,015 in FY2025 with a 5-year CAGR of -30.8%.
Declined from $688,680 to $190,015 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -17.8%
- 5-Year CAGR
- -30.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -30.8%, indicating a declining trend.
- In FY2025, capital expenditures decreased 36.1% year-over-year.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $190.0K | -36.1% |
| FY2024 | $297.5K | -56.8% |
| FY2023 | $688.7K | +101.4% |
| FY2022 | $342.0K | -74.1% |
| FY2021 | $1.3M | +10.1% |
| FY2020 | $1.2M | +4987.7% |
| FY2019 | $23.6K | +195.7% |
| FY2018 | $8.0K | -93.7% |
| FY2017 | $127.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026